Combined Intermittent Pneumatic Leg Compression and Pharmacological Prophylaxis for Prevention of Venous Thrombo-Embolism in High-Risk Patients

Abstract Background It has been suggested that combined modalities (methods of treatment) are more effective than single modalities in preventing venous thrombo-embolism (defined as deep vein thrombosis and pulmonary embolism, or both) in high-risk patients. Objectives To assess the efficacy of inte...

Full description

Saved in:
Bibliographic Details
Published in:European journal of vascular and endovascular surgery 2009-03, Vol.37 (3), p.364-365
Main Authors: Kakkos, S.K, Caprini, J.A, Geroulakos, G, Nicolaides, A.N, Stansby, G.P, Reddy, D.J
Format: Article
Language:English
Subjects:
Aspirin - therapeutic use
Clinical Trials as Topic
DVT
Fibrinolytic Agents - therapeutic use
Humans
Intermittent Pneumatic Compression Devices
Pulmonary Embolism - prevention & control
Surgery
Venous Thrombosis - prevention & control
VTE
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background It has been suggested that combined modalities (methods of treatment) are more effective than single modalities in preventing venous thrombo-embolism (defined as deep vein thrombosis and pulmonary embolism, or both) in high-risk patients. Objectives To assess the efficacy of intermittent pneumatic leg compression combined with pharmacological prophylaxis versus single modalities in preventing venous thrombo-embolism in high-risk patients. Search strategy The Cochrane Peripheral Vascular Diseases (PVD) Group searched the reference lists of their Specialised Register (last searched 17 July 2007) and the Cochrane Central Register of Controlled Trials (CENTRAL) (last searched The Cochrane Library 2008, issue 3) for relevant articles to identify additional trials. Selection criteria Randomised controlled trials (RCTs) or controlled clinical trials (CCTs) of combined intermittent pneumatic leg compression and pharmacological interventions used to prevent venous thrombo-embolism in high-risk patients. Data collection and analysis Data extraction was undertaken independently by two review authors using data extraction sheets.
ISSN:1078-5884
1532-2165
DOI:10.1016/j.ejvs.2008.11.033